Defective CFTR leads to aberrant β-catenin activation and kidney fibrosis

Abstract Cystic fibrosis transmembrane conductance regulator (CFTR), known as a cAMP-activated Cl− channel, is widely expressed at the apical membrane of epithelial cells in a wide variety of tissues. Of note, despite the abundant expression of CFTR in mammalian kidney, the role of CFTR in kidney di...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jie Ting Zhang, Yan Wang, Jun Jiang Chen, Xiao Hu Zhang, Jian Da Dong, Lai Ling Tsang, Xiao Ru Huang, Zhiming Cai, Hui Yao Lan, Xiao Hua Jiang, Hsiao Chang Chan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/12e229d7fb814a3bb6c5e7916e428cd8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:12e229d7fb814a3bb6c5e7916e428cd8
record_format dspace
spelling oai:doaj.org-article:12e229d7fb814a3bb6c5e7916e428cd82021-12-02T11:52:57ZDefective CFTR leads to aberrant β-catenin activation and kidney fibrosis10.1038/s41598-017-05435-52045-2322https://doaj.org/article/12e229d7fb814a3bb6c5e7916e428cd82017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05435-5https://doaj.org/toc/2045-2322Abstract Cystic fibrosis transmembrane conductance regulator (CFTR), known as a cAMP-activated Cl− channel, is widely expressed at the apical membrane of epithelial cells in a wide variety of tissues. Of note, despite the abundant expression of CFTR in mammalian kidney, the role of CFTR in kidney disease development is unclear. Here, we report that CFTR expression is downregulated in the UUO (unilateral ureteral obstruction)-induced kidney fibrosis mouse model and human fibrotic kidneys. Dysfunction or downregulation of CFTR in renal epithelial cells leads to alteration of genes involved in Epithelial-Mesenchymal Transition (EMT) and kidney fibrosis. In addition, dysregulation of CFTR activates canonical Wnt/β-catenin signaling pathways, whereas the β-catenin inhibitor reverses the effects of CFTR downregulation on EMT marker. More interestingly, CFTR interacts with Dishevelled 2 (Dvl2), a key component of Wnt signaling, thereby suppressing the activation of β-catenin. Compared to wild type, deltaF508 mice with UUO treatment exhibit significantly higher β-catenin activity with aggregated kidney fibrogenesis, which is reduced by forced overexpression of CFTR. Taken together, our study reveals a novel mechanism by which CFTR regulates Wnt/β-catenin signaling pertinent to progression of kidney fibrosis and indicates a potential treatment target.Jie Ting ZhangYan WangJun Jiang ChenXiao Hu ZhangJian Da DongLai Ling TsangXiao Ru HuangZhiming CaiHui Yao LanXiao Hua JiangHsiao Chang ChanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jie Ting Zhang
Yan Wang
Jun Jiang Chen
Xiao Hu Zhang
Jian Da Dong
Lai Ling Tsang
Xiao Ru Huang
Zhiming Cai
Hui Yao Lan
Xiao Hua Jiang
Hsiao Chang Chan
Defective CFTR leads to aberrant β-catenin activation and kidney fibrosis
description Abstract Cystic fibrosis transmembrane conductance regulator (CFTR), known as a cAMP-activated Cl− channel, is widely expressed at the apical membrane of epithelial cells in a wide variety of tissues. Of note, despite the abundant expression of CFTR in mammalian kidney, the role of CFTR in kidney disease development is unclear. Here, we report that CFTR expression is downregulated in the UUO (unilateral ureteral obstruction)-induced kidney fibrosis mouse model and human fibrotic kidneys. Dysfunction or downregulation of CFTR in renal epithelial cells leads to alteration of genes involved in Epithelial-Mesenchymal Transition (EMT) and kidney fibrosis. In addition, dysregulation of CFTR activates canonical Wnt/β-catenin signaling pathways, whereas the β-catenin inhibitor reverses the effects of CFTR downregulation on EMT marker. More interestingly, CFTR interacts with Dishevelled 2 (Dvl2), a key component of Wnt signaling, thereby suppressing the activation of β-catenin. Compared to wild type, deltaF508 mice with UUO treatment exhibit significantly higher β-catenin activity with aggregated kidney fibrogenesis, which is reduced by forced overexpression of CFTR. Taken together, our study reveals a novel mechanism by which CFTR regulates Wnt/β-catenin signaling pertinent to progression of kidney fibrosis and indicates a potential treatment target.
format article
author Jie Ting Zhang
Yan Wang
Jun Jiang Chen
Xiao Hu Zhang
Jian Da Dong
Lai Ling Tsang
Xiao Ru Huang
Zhiming Cai
Hui Yao Lan
Xiao Hua Jiang
Hsiao Chang Chan
author_facet Jie Ting Zhang
Yan Wang
Jun Jiang Chen
Xiao Hu Zhang
Jian Da Dong
Lai Ling Tsang
Xiao Ru Huang
Zhiming Cai
Hui Yao Lan
Xiao Hua Jiang
Hsiao Chang Chan
author_sort Jie Ting Zhang
title Defective CFTR leads to aberrant β-catenin activation and kidney fibrosis
title_short Defective CFTR leads to aberrant β-catenin activation and kidney fibrosis
title_full Defective CFTR leads to aberrant β-catenin activation and kidney fibrosis
title_fullStr Defective CFTR leads to aberrant β-catenin activation and kidney fibrosis
title_full_unstemmed Defective CFTR leads to aberrant β-catenin activation and kidney fibrosis
title_sort defective cftr leads to aberrant β-catenin activation and kidney fibrosis
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/12e229d7fb814a3bb6c5e7916e428cd8
work_keys_str_mv AT jietingzhang defectivecftrleadstoaberrantbcateninactivationandkidneyfibrosis
AT yanwang defectivecftrleadstoaberrantbcateninactivationandkidneyfibrosis
AT junjiangchen defectivecftrleadstoaberrantbcateninactivationandkidneyfibrosis
AT xiaohuzhang defectivecftrleadstoaberrantbcateninactivationandkidneyfibrosis
AT jiandadong defectivecftrleadstoaberrantbcateninactivationandkidneyfibrosis
AT lailingtsang defectivecftrleadstoaberrantbcateninactivationandkidneyfibrosis
AT xiaoruhuang defectivecftrleadstoaberrantbcateninactivationandkidneyfibrosis
AT zhimingcai defectivecftrleadstoaberrantbcateninactivationandkidneyfibrosis
AT huiyaolan defectivecftrleadstoaberrantbcateninactivationandkidneyfibrosis
AT xiaohuajiang defectivecftrleadstoaberrantbcateninactivationandkidneyfibrosis
AT hsiaochangchan defectivecftrleadstoaberrantbcateninactivationandkidneyfibrosis
_version_ 1718394908449964032